CON vs EHC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EHC Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Encompass Health Corporation Common Stock (EHC) driven by superior Valuation, Growth & Margin while CON counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CON trades at 22.0x Forward P/E with 17.2% operating margin (+8.6% YoY revenue) versus EHC at 19.4x Forward P/E and 18.4% operating margin (+8.9% YoY). In options structure, CON sits in BREAKOUT (95th %ile IV; Dealer Gamma Walls on Pro) against EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CON Revenue | EHC Revenue | CON Op. Margin | EHC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $4.28B | N/A | 13.0% | EHC |
| FY2019 | N/A | $4.61B | N/A | 13.3% | EHC |
| FY2020 | N/A | $3.57B | N/A | 15.8% | EHC |
| FY2021 | N/A | $4.01B | N/A | 13.9% | EHC |
| FY2022 | $1.72B | $4.35B | 15.0% | 12.4% | CON |
| FY2023 | $1.84B | $4.80B | 15.6% | 7.3% | CON |
| FY2024 | $1.90B | $5.37B | 16.0% | 8.5% | CON |
| FY2025 | $2.16B | $5.94B | 15.4% | 9.5% | CON |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CON | EHC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $13.0B | Larger Scale | EHC |
| Trailing P/E Ratio Valuation | 24.5x | 21.2x | Lower Multiple | EHC |
| Forward P/E Ratio Valuation | 22.0x | 19.4x | Lower Multiple | EHC |
| Revenue Growth (YoY) Growth | +8.6% | +8.9% | Higher Growth | EHC |
| Operating Margin (TTM) Profitability | 17.2% | 18.4% | Higher Margin | EHC |
| Net Profit Margin Profitability | 9.3% | 10.2% | Higher Margin | EHC |
| Return on Equity (ROE) Capital Efficiency | 47.2% | 25.1% | Higher ROE | CON |
| 52-Week Range Position Momentum | 91% ($19โ$44) | 80% ($93โ$144) | Stronger Trend | CON |
| Beta / 30D Volatility Risk Regime | 0.52ฮฒ ยท 38% Vol | -0.10ฮฒ ยท 40% Vol | Lower Realized Risk | CON |
| Unified Institutional Score Composite Signal | 43.5 / 100 (HOLD) | 52.0 / 100 (HOLD) | Higher Composite | EHC |